Dr. Zalom is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8700 Beverly Blvd
Department of Medicine Residency Training Program
West Hollywood, CA 90048Phone+1 310-423-2924
Education & Training
- Olive View/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
- Cedars-Sinai Medical CenterResidency, Internal Medicine, 2007 - 2010
- University of California San Diego School of MedicineClass of 2007
Certifications & Licensure
- CA State Medical License 2008 - 2026
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma Start of enrollment: 2012 Feb 01
Publications & Presentations
PubMed
- 10 citationsFDG PET/CT as a prognostic test after 90Y radioembolization in patients with metastatic hepatic disease.Martina Zalom, Run Yu, Marc L. Friedman, Catherine Bresee, Alan D. Waxman
Clinical Nuclear Medicine. 2012-09-01 - 6 citationsCisplatin-Induced Renal Salt Wasting Requiring over 12 Liters of 3% Saline Replacement.Phuong-Chi T. Pham, Pavani Reddy, Shaker Qaqish, Ashvin Kamath, Johana Rodriguez
Case Reports in Nephrology. 2017-05-10 - 2 citationsA Lymphoma Almost Overlooked.Jeremy Lorber, Martina Zalom
Cureus. 2018-01-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: